ABSTRACT
Background Tuberculosis (TB) is the most deadly infectious disease globally and highly prevalent in the developing world, especially sub-Saharan Africa. Even though a third of humans are exposed to Myocbacterium tuberculosis (Mtb), most infected immunocompetent individuals do not develop active TB. In contrast, for individuals infected with both TB and the human immunodeficiency virus (HIV), the risk of active disease is 10% or more per year. Previously, we identified in a genome-wide association study a region on chromosome 5 that was associated with resistance to TB. This region included epigenetic marks that could influence gene regulation so we hypothesized that HIV-infected individuals exposed to Mtb, who remain disease free, carry epigenetic changes that strongly protect them from active TB. To test this hypothesis, we conducted a methylome-wide study in HIV-infected, TB-exposed cohorts from Uganda and Tanzania.
Results In 221 HIV-infected adults from Uganda and Tanzania, we identified 3 regions of interest that included markers that were differentially methylated between TB cases and LTBI controls, that also included methylation QTLs and associated SNPs: chromosome 1 (RNF220, p=4×10−5), chromosome 2 (between COPS8 and COL6A3 genes, p=2.7×10−5), and chromosome 5 (CEP72, p=1.3×10−5). These methylation results colocalized with associated SNPs, methylation QTLs, and methylation × SNP interaction effects. These markers were in regions with regulatory markers for cells involved in TB immunity and/or lung.
Conclusion Epigenetic regulation is a potential biologic factor underlying resistance to TB in immunocompromised individuals that can act in conjunction with genetic variants.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by NIH grants R56 AI130947 and R01AI124348. Recruitment and characterization of Ugandan study subjects was funded by grant N01-AI95383 and HHSN266200700022C/ N01-AI70022 from the NIAID.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Informed consent was obtained from all patients in the extended DarDar follow-up cohort. The research ethics committee at the Muhimbili University of Health and Allied Sciences and the Committee for the Protection of Human Subjects at Dartmouth College and the Dartmouth-Hitchcock Medical Center approved this study. Informed consent was obtained from all subjects in the Household Contact study in Kampala, Uganda. Ethics committees that approved this work were at Muhimbili University of Health and Allied Sciences, Committee for the Protection of Human Subjects at Dartmouth College (#14606), Uganda Council for Science and Technology, and University Hospitals of Cleveland (10-01-25)
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Summary data (marker names and p-values) will be provided at Dryad (https://github.com/CDL-Dryad/dryad). The Ugandan IRB did not grant approval for broad genetic data sharing, so individual-level data may be requested from the Data Access Committee, chaired by Dr. Sudha Iyengar (ski@case.edu). Methylation data from the Tanzanian cohort will be available at Dryad (https://github.com/CDL-Dryad/dryad).
LIST OF ABBREVIATIONS
- ARVs
- anti-retroviral therapy
- GWAS
- genome-wide association study
- HIV
- Human Immunodeficiency virus
- LTBI
- latent M. tuberculosis infection
- meQTL
- methylation quantitative trait locus
- Mtb
- Mycobacterium tuberculosis
- MWAS
- methylome-wide association study
- SNP
- single nucleotide polymorphism
- TB
- Tuberculosis
